Introduction

"Infection is the
major cause of
implant failure. On
average, 5% of all
biomaterial-implant
patients experience
severe complications,
mainly due to
infection”

The Biomaterials Development Center (BDC) is seeking a number of major device and material companies to invest in a long term partnership to co-develop biomaterials.

By combining the extensive knowledge, facilities and resources of the BDC together with the market knowledge, engineering skills and resources of proven medical device/material companies, we aim to jointly develop new infection-resistant materials for clinical application.

The BDC coordinates and aligns the development of infection-resistant biomaterials from bench to bed using a number of key departments within the University Medical Center Groningen (UMCG) and the University of Groningen (RUG).

The website of BDC uses functional and anonymous analytics cookies. By continuing on this website and/or closing this message you accept this cookies!